v3.25.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net sales $ 1,259.1 $ 1,281.1 $ 2,480.8 $ 2,545.4
Cost of sales [1],[2] 276.9 283.1 542.1 568.1
Gross profit 982.2 998.0 1,938.7 1,977.3
Royalty overrides 406.5 415.3 808.3 830.5
Selling, general, and administrative expenses 447.9 502.3 879.8 994.5
Other operating income (4.8) 0.0 (4.8) 0.0
Operating income 132.6 80.4 255.4 152.3
Interest expense, net 53.6 57.7 105.6 95.6
Other expense, net 0.0 10.5 0.0 10.5
Income before income taxes 79.0 12.2 149.8 46.2
Income taxes 29.8 7.5 50.2 17.2
Net income 49.2 4.7 99.6 29.0
Net loss attributable to noncontrolling interest (0.1) 0.0 (0.1) 0.0
Net income attributable to Herbalife $ 49.3 $ 4.7 $ 99.7 $ 29.0
Earnings per share attributable to Herbalife:        
Basic $ 0.48 $ 0.05 $ 0.98 $ 0.29
Diluted $ 0.48 $ 0.05 $ 0.97 $ 0.29
Weighted-average shares outstanding:        
Basic 102.7 100.6 102.2 100.1
Diluted 103.3 101.7 102.8 101.2
[1] As a result of adopting ASU 2023-07 during the fourth quarter of 2024, the Company has expanded and updated its disclosures for the current year and prior year periods as described in Note 2, Basis of Presentation, to the Consolidated Financial Statements included in the 2024 10-K.
[2] The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.